Clinical Trial Update: The Safety of Boostrix Following Routine Immunization of Pregnant Women

View source ↗

Summary

Clinical trial update assessing the safety of Boostrix administered after routine immunization of pregnant women.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Whooping Cough

Drugs mentioned

• Boostrix (Diphtheria, Tetanus, and Acellular Pertussis Vaccine)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Whooping Cough | Status: COMPLETED | Results posted: 2022-05-18